ja.cabrera
Submits third-party assay reports on material purchased directly. Based in Malmö.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.92%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042887 | CJC-1295 with DAC | MKM | MKM-2602-M1973 | Kestrel | 2026-Q1 | 99.93 | 3.83 | 91.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019054 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B3061 | Janoshik | 2025-Q4 | 99.25 | 4.80 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020313 | Semaglutide | MKM | MKM-2507-D3230 | Janoshik | 2025-Q4 | 98.61 | 4.45 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020152 | Semax | GGPeps | GGPE-2510-C9080 | Nordanalyt | 2025-Q4 | 98.89 | 8.04 | 100.0 | Laboratory-retained | 0 | PASS |
| AX-2025-019118 | BPC-157 | JEEP | JEEP-2507-V4206 | PeptideMeter | 2025-Q3 | 99.50 | 4.91 | 106.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018848 | BPC-157 | QSC | QSC-2412-D8748 | PeptideMeter | 2025-Q1 | 98.92 | 5.53 | 89.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020785 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | Medutest | 2025-Q1 | 98.32 | 6.35 | 90.3 | Supplier-supplied | 2 | FAIL |
| AX-2025-020138 | Enclomiphene citrate | GGPeps | GGPE-2410-S9487 | Janoshik | 2025-Q1 | 98.63 | 3.77 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-005130 | Sermorelin | KP | KP-2312-R4578 | Janoshik | 2024-Q2 | 99.57 | 7.31 | 89.1 | Supplier-supplied | 1 | MARGINAL |